Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company’s Board of Directors (the "Board"), ...

Masimo has expanded the board with the addition of former Stryker President Timothy Scannell and Lane Holdings Chair Wendy ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $165.00.

IRVINE, Calif. - Masimo (NASDAQ:MASI) Corporation (NASDAQ:MASI), known for its medical technology innovations, has appointed Timothy J. Scannell and Wendy E. Lane to its Board of Directors.

Irvine-based Masimo Corp. announced it has added Timothy Scannell and Wendy Lane to its board of directors, effective ...

Northwestern Mutual Wealth Management Co. grew its position in Masimo Co. (NASDAQ:MASI – Free Report) by 133.3% during the ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where ...

In a report released today, Michael Matson from Needham maintained a Hold rating on ICU Medical (ICUI – Research Report). The ...

(see more details here). Masimo Corporation (NASDAQ:MASI) is a medical devices company that primarily makes and sells monitoring devices. Its products enable healthcare providers to monitor ...

Irvine, CA-based Masimo Corporation develops ... Momentum investors should take note of this Medical stock. MASI has a Momentum Style Score of A, and shares are up 25.2% over the past four ...